DECREASED PLASMA HALF-LIFE OF CYCLOPHOSPHAMIDE DURING REPEATED HIGH-DOSE ADMINISTRATION

被引：1
|
作者：
GRAHAM, MI
SHAW, IC
SOUHAMI, RL
SIDAU, B
HARPER, PG
MCLEAN, AEM
机构：
[1] UNIV COLL HOSP LONDON, DEPT RADIOTHERAPY & ONCOL, LONDON WC1E 6JJ, ENGLAND
[2] UCL, DEPT CLIN PHARMACOL, TOXICOL & PHARMACOKINET LAB, LONDON WC1, ENGLAND
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1983年 / 10卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：192 / 193
页数：2
相关论文
共 50 条
  • [1] DECREASED HALF-LIFE OF IFOSFAMIDE AFTER REPEATED ADMINISTRATION IN LUNG-CANCER PATIENTS
    LIND, M
    CERNY, T
    MARGISON, JM
    THATCHER, N
    WILKINSON, P
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S101 - S101
  • [2] DECREASED HALF-LIFE OF CYCLOPHOSPHAMIDE IN PATIENTS UNDER CONTINUAL TREATMENT
    DINCALCI, M
    BOLIS, G
    FACCHINETTI, T
    MANGIONI, C
    MORASCA, L
    MORAZZONI, P
    SALMONA, M
    EUROPEAN JOURNAL OF CANCER, 1979, 15 (01) : 7 - 10
  • [3] CYCLOPHOSPHAMIDE (CP) PHARMACOKINETICS AND METABOLISM AFTER REPEATED HIGH-DOSE ADMINISTRATION IN BMT
    EHNINGER, G
    SCHULER, U
    WAGNER, T
    OSTENDORF, P
    EXPERIMENTAL HEMATOLOGY, 1985, 13 : 153 - 153
  • [4] PLASMA HALF-LIFE AND URINARY-EXCRETION OF CYCLOPHOSPHAMIDE IN CHILDREN
    SLADEK, NE
    PRIEST, J
    DOEDEN, D
    MIROCHA, CJ
    PATHRE, S
    KRIVIT, W
    CANCER TREATMENT REPORTS, 1980, 64 (10-1): : 1061 - 1066
  • [5] REPEATED HIGH-DOSE CYCLOPHOSPHAMIDE ADMINISTRATION IN BONE-MARROW TRANSPLANTATION - EXPOSURE TO ACTIVATED METABOLITES
    SCHULER, U
    EHNINGER, G
    WAGNER, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1987, 20 (03) : 248 - 252
  • [6] REPEATED HIGH-DOSE CYCLOPHOSPHAMIDE ADMINISTRATION IN BONE-MARROW TRANSPLANTATION - EXPOSURE TO ACTIVATED METABOLITES
    SCHULER, U
    EHNINGER, G
    WAGNER, T
    BLUT, 1986, 53 (03): : 194 - 194
  • [7] HALF-LIFE OF PLASMA CORTICOSTERONE DURING DEVELOPMENT
    SCHAPIRO, S
    PERCIN, CJ
    KOTICHAS, FJ
    ENDOCRINOLOGY, 1971, 89 (01) : 284 - &
  • [8] HALF-LIFE OF RIFAMPICIN AFTER REPEATED ADMINISTRATION OF DIFFERENT DOSES IN HUMANS
    CURCI, G
    DELLIVEN.F
    NINNI, A
    NITTI, V
    BERGAMINI, N
    CHEMOTHERAPY, 1972, 17 (06) : 373 - +
  • [9] HUMAN-PLASMA PHARMACOKINETICS OF THIOTEPA FOLLOWING ADMINISTRATION OF HIGH-DOSE THIOTEPA AND CYCLOPHOSPHAMIDE
    ACKLAND, SP
    CHOI, KE
    RATAIN, MJ
    EGORIN, MJ
    WILLIAMS, SF
    SINKULE, JA
    BITRAN, JD
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (07) : 1192 - 1196
  • [10] DECREASED GENTAMICIN HALF-LIFE DURING PERITONEAL-DIALYSIS
    BLOUIN, RA
    BAUER, LA
    PIECORO, JJ
    HOLLAND, NH
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1980, 14 (03): : 218 - 219
12345